LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | -96.7% | 2 | -96.0% | 0.00% | -100.0% |
| Q2 2023 | $3,605 | -2.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,678 | +10.1% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,340 | -16.5% | 50 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | 0.0% | 49 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | – | 41 | +1266.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 3 | -93.8% | 0.00% | -100.0% |
| Q3 2021 | $7,000 | +40.0% | 48 | +182.4% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | +25.0% | 17 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $4,000 | +33.3% | 17 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | +50.0% | 17 | +30.8% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 13 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | 0.0% | 13 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | +100.0% | 13 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 13 | +30.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |